<DOC>
	<DOC>NCT01144949</DOC>
	<brief_summary>The purpose of this study is to assess if patients treated with silodosin will have a higher spontaneous passage rate of their ureteral stone than those treated with placebo.</brief_summary>
	<brief_title>Study of Silodosin to Facilitate Passage of Urinary Stones</brief_title>
	<detailed_description />
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Urolithiasis</mesh_term>
	<mesh_term>Urinary Calculi</mesh_term>
	<mesh_term>Ureteral Calculi</mesh_term>
	<mesh_term>Ureterolithiasis</mesh_term>
	<mesh_term>Silodosin</mesh_term>
	<criteria>At least 18 years of age or older Male or a nonpregnant, nonlactating female using adequate means of birth control, if not menopausal Have radiopaque unilateral ureteral calculus ≥4mm and ≤10mm in any location of the ureter Multiple ureteral calculi, or a solitary kidney, or refractory renal colic, or a nonopaque calculus, or active urinary tract infection, or severe hydronephrosis History of previous ureteral surgery or ureteral stricture on affected side History of any of the following conditions: myasthenia gravis, myopathy, spina bifida, spinal cord injury, autonomic nervous system disorder, fibromyalgia, breast cancer Moderate to severe renal impairment or severe liver insufficiency History of significant postural hypotension Is receiving medication(s) which preclude safe participation in the study or that may produce a confounding effect on the variables under study History of allergy to alphablockers or oxycodone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>ureteral calculi</keyword>
	<keyword>renal colic</keyword>
	<keyword>ureteral stones</keyword>
	<keyword>kidney stones</keyword>
	<keyword>medical expulsive therapy</keyword>
</DOC>